PRIMUS Sterilizer
PRIMUS Sterilizer names Jim Fry as CEO

March 13, 2015, Omaha, NE – PRIMUS Sterilizer announced today that the Board of Directors has appointed Jim Fry as Chief Executive Officer and a member of the Board of Directors effectively immediately. Fry brings with him a deep operating history and broad market experience in the life science and healthcare industry. Jim has led and been a member of executive teams that developed global solutions for customers in the key segments that PRIMUS operates in.

Prior to joining PRIMUS, Jim held multiple roles within Getinge including President of LANCER USA, SVP Getinge North America, and a member of Getinge’s Portfolio Decision Board that was responsible for all product life cycle decisions inside the Infection Control Division of the Getinge Group. Jim’s last position with Getinge was head of its newly formed Life Science business unit with P&L responsibility for the Americas region as well as a member of the global Life Science Management team.

Former CEO Michael Douglas is stepping down after 6 years with PRIMUS. During Michael’s tenure at PRIMUS, he successfully led the company through numerous facility consolidation initiatives and greatly expanded the operating margins of the business. Michael will assist Jim during a transition period.

PRIMUS is a portfolio company of Blue Sage Capital, an Austin, Texas based private equity firm with $250 million of assets under management. Blue Sage co-founding partner, Peter Huff, commented, “We are very appreciative of Michael’s leadership at PRIMUS and thank him for his hard work. We are thrilled to have Jim join the PRIMUS family and believe his extensive background in the industry will serve him well as he leads the company. Jim is a proven leader with a vision for PRIMUS. Both Blue Sage and Jim believe PRIMUS is a market leader in the steam sterilizer industry and we look forward to a successful partnership with Jim.”

For questions or inquiries, please contact Matt Binderup at 402-344-4200 or email This e-mail address is being protected from spambots. You need JavaScript enabled to view it .